Search results
Rydapt dosage: Form, strength, how to take, and more
Medical News Today· 4 days agoYour doctor will determine the best dosage to fit your needs. Doctors may prescribe Rydapt to treat AML in adults with a certain genetic mutation. If...
ComboMATCH Precision Medicine Cancer Trials
National Cancer Institute· 3 days ago(Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice) is a group of precision medicine cancer clinical trials, including a...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 3 days agoLive from ASCO 2024 | Updated Data of Bcl-2 Inhibitor Lisaftoclax Combined with Azacitidine in Patients with AML Demonstrate Promising Efficacy and Manageable Safety PR Newswire SUZHOU, China ...
Bio-Path secures $4 million in private placement By Investing.com
Investing.com· 3 days agoBio-Path Holdings, Inc. (NASDAQ:BPTH), a biotechnology firm, announced today it has entered into a...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 6 days agoIn honor of National Cancer Survivor Month this June, the St. Baldrick's Foundation, the largest charity funder of childhood cancer research grants, is launching its "Cancer-Free Isn't Free" ...
GSK builds case for return of multiple myeloma drug Blenrep
BioPharma Dive via Yahoo Finance· 5 days agoStudy results showed the antibody-drug conjugate helped stave off disease progression better than a...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 4 days agoLive from ASCO 2024 | Ascentage Pharma Releases Updated Data Showing Promising Efficacy and Safety of Lisaftoclax in Patients with WM PR Newswire SUZHOU, China, and ROCKVILLE, Md., June 4, 2024 ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 2 days agoLive from ASCO 2024 | Oral Report Released Latest Data of Olverembatinib in SDH-Deficient GIST, Including a CBR of 92.3% PR Newswire SUZHOU, China and ROCKVILLE, Md., June 4, 2024 SUZHOU, China ...
Blenrep-Based Regimen Yields PFS Benefit in Relapsed/Refractory Myeloma
MedPage Today· 6 days agoProgression-free survival (PFS) was significantly higher with belantamab mafodotin (belamaf;...
Crude Oil Down Over 3%; US Construction Spending Falls In May - Lattice Semiconductor (NASDAQ:LSCC)
Benzinga· 4 days agoThe S&P 500 also fell, dropping, 0.20% to 5,266.90. U.S. construction spending declined by 0.1%...